These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 29867968)

  • 1. Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines.
    Hiršl L; Brizić I; Jenuš T; Juranić Lisnić V; Reichel JJ; Jurković S; Krmpotić A; Jonjić S
    Front Immunol; 2018; 9():991. PubMed ID: 29867968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memory CD8 T Cells Generated by Cytomegalovirus Vaccine Vector Expressing NKG2D Ligand Have Effector-Like Phenotype and Distinct Functional Features.
    Šustić M; Cokarić Brdovčak M; Lisnić B; Materljan J; Juranić Lisnić V; Rožmanić C; Indenbirken D; Hiršl L; Busch DH; Brizić I; Krmpotić A; Jonjić S
    Front Immunol; 2021; 12():681380. PubMed ID: 34168650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.
    Slavuljica I; Busche A; Babić M; Mitrović M; Gašparović I; Cekinović D; Markova Car E; Pernjak Pugel E; Ciković A; Lisnić VJ; Britt WJ; Koszinowski U; Messerle M; Krmpotić A; Jonjić S
    J Clin Invest; 2010 Dec; 120(12):4532-45. PubMed ID: 21099111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior induction and maintenance of protective CD8 T cells in mice infected with mouse cytomegalovirus vector expressing RAE-1γ.
    Trsan T; Busche A; Abram M; Wensveen FM; Lemmermann NA; Arapovic M; Babic M; Tomic A; Golemac M; Brinkmann MM; Jäger W; Oxenius A; Polic B; Krmpotic A; Messerle M; Jonjic S
    Proc Natl Acad Sci U S A; 2013 Oct; 110(41):16550-5. PubMed ID: 24052528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.
    Lodoen M; Ogasawara K; Hamerman JA; Arase H; Houchins JP; Mocarski ES; Lanier LL
    J Exp Med; 2003 May; 197(10):1245-53. PubMed ID: 12756263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions.
    Lodoen MB; Abenes G; Umamoto S; Houchins JP; Liu F; Lanier LL
    J Exp Med; 2004 Oct; 200(8):1075-81. PubMed ID: 15477345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145.
    Krmpotic A; Hasan M; Loewendorf A; Saulig T; Halenius A; Lenac T; Polic B; Bubic I; Kriegeskorte A; Pernjak-Pugel E; Messerle M; Hengel H; Busch DH; Koszinowski UH; Jonjic S
    J Exp Med; 2005 Jan; 201(2):211-20. PubMed ID: 15642742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus vector expressing RAE-1γ induces enhanced anti-tumor capacity of murine CD8
    Tršan T; Vuković K; Filipović P; Brizić AL; Lemmermann NAW; Schober K; Busch DH; Britt WJ; Messerle M; Krmpotić A; Jonjić S
    Eur J Immunol; 2017 Aug; 47(8):1354-1367. PubMed ID: 28612942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promiscuity of MCMV immunoevasin of NKG2D: m138/fcr-1 down-modulates RAE-1epsilon in addition to MULT-1 and H60.
    Arapović J; Lenac Rovis T; Reddy AB; Krmpotić A; Jonjić S
    Mol Immunol; 2009 Nov; 47(1):114-22. PubMed ID: 19297023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine cytomegalovirus regulation of NKG2D ligands.
    Lenac T; Arapović J; Traven L; Krmpotić A; Jonjić S
    Med Microbiol Immunol; 2008 Jun; 197(2):159-66. PubMed ID: 18259774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus.
    Arapovic J; Lenac T; Antulov R; Polic B; Ruzsics Z; Carayannopoulos LN; Koszinowski UH; Krmpotic A; Jonjic S
    J Virol; 2009 Aug; 83(16):8198-207. PubMed ID: 19494006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein.
    Hasan M; Krmpotic A; Ruzsics Z; Bubic I; Lenac T; Halenius A; Loewendorf A; Messerle M; Hengel H; Jonjic S; Koszinowski UH
    J Virol; 2005 Mar; 79(5):2920-30. PubMed ID: 15709011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication.
    Morello CS; Ye M; Spector DH
    J Virol; 2002 May; 76(10):4822-35. PubMed ID: 11967299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.
    Lenac T; Budt M; Arapovic J; Hasan M; Zimmermann A; Simic H; Krmpotic A; Messerle M; Ruzsics Z; Koszinowski UH; Hengel H; Jonjic S
    J Exp Med; 2006 Aug; 203(8):1843-50. PubMed ID: 16831899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection.
    Gergely KM; Podlech J; Becker S; Freitag K; Krauter S; Büscher N; Holtappels R; Plachter B; Reddehase MJ; Lemmermann NAW
    Front Immunol; 2021; 12():694588. PubMed ID: 34489940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic cell-mediated dissemination of murine cytomegalovirus is regulated by NK cells and immune evasion.
    Zhang S; Springer LE; Rao HZ; Espinosa Trethewy RG; Bishop LM; Hancock MH; Grey F; Snyder CM
    PLoS Pathog; 2021 Jan; 17(1):e1009255. PubMed ID: 33508041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection.
    Bongard N; Le-Trilling VTK; Malyshkina A; Rückborn M; Wohlgemuth K; Wensing I; Windmann S; Dittmer U; Trilling M; Bayer W
    PLoS Pathog; 2019 Sep; 15(9):e1008043. PubMed ID: 31568492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The context of gene expression defines the immunodominance hierarchy of cytomegalovirus antigens.
    Dekhtiarenko I; Jarvis MA; Ruzsics Z; Čičin-Šain L
    J Immunol; 2013 Apr; 190(7):3399-409. PubMed ID: 23460738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells.
    Holtappels R; Thomas D; Podlech J; Geginat G; Steffens HP; Reddehase MJ
    J Virol; 2000 Feb; 74(4):1871-84. PubMed ID: 10644360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of multiple DNA vaccines for protection against cytomegalovirus infection in BALB/c mice.
    Huang C; Wang H; Wu S; Chang H; Liu L; Peng B; Fang F; Chen Z
    Virol J; 2014 Jun; 11():104. PubMed ID: 24898886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.